| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_451978e2bebec8807035c34eb4bad43e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74eaab766cc0e87736233bc4e66edd90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f9a60df104240e2f911e94c4b04ed96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_482f5c56e5836ebb7043cc898912f413 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-00 |
| filingDate |
2009-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dadbe266ca584405bd2f7f3ba96c90ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8814a8673c82db53a6f0892f3460aaf5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45369f0cc209f74e1629ba8f21c654f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_260b3f4e231141b6549183252aa50a3f |
| publicationDate |
2013-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8513224-B2 |
| titleOfInvention |
Crystalline form C of tigecycline dihydrochloride and methods for its preparation |
| abstract |
The present invention relates to crystalline form C of Tigecycline dihydrochloride and to methods for the preparation of the same. Furthermore the present invention relates to the use of crystalline form C of Tigecycline dihydrochloride as an intermediate for the preparation of an anti-infective medicament. Moreover the present invention relates to pharmaceutical compositions comprising crystalline form C of Tigecycline dihydrochloride in an effective amount and to the use of crystalline form C of Tigecycline dihydrochloride as an anti-infective medicament. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11492342-B2 |
| priorityDate |
2008-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |